Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
BioScrip Inc Closes Acquisition of DaVita HealthCare Partners Inc's Subsidiary HomeChoice Partners Inc
BioScrip Inc announced the February 1, 2013 closing of its previously announced agreement to acquire HomeChoice Partners Inc, provider of alternate-site infusion pharmacy services, for $70.0 million in cash. HomeChoice was a majority-owned subsidiary of DaVita HealthCare Partners Inc.
Latest Key Developments in Healthcare
- NICHII GAKKAN CO Amends Consolidated Mid-year Outlook for FY 2014
- Cryo Save Group NV Appoints Walter van Pottelberge As Chairman To Replace Johan Goossens-DJ
- Feelgood Svenska publ AB to Acquire Hagabadet Holding AB
- Primary Health Properties PLC Announces Proposed Firm Placing And Placing, Open Offer
- Share this
- Link this
- Digg this
Follow Reuters